Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.848
+0.042 (5.16%)
At close: Apr 28, 2026, 4:00 PM EDT
0.850
+0.003 (0.29%)
After-hours: Apr 28, 2026, 6:08 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $188.16 million as of April 28, 2026. Its market cap has decreased by -22.74% in one year.
Market Cap
188.16M
Enterprise Value
197.79M
1-Year Change
-22.74%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $188.16M, an increase of 51.37%. That is a compound annual growth rate of 7.97%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 191.63M |
| Canton Strategic Holdings | 190.65M |
| Korro Bio | 186.05M |
| Cartesian Therapeutics | 183.31M |
| Precision BioSciences | 181.65M |
| Unicycive Therapeutics | 181.21M |
| Acumen Pharmaceuticals | 179.81M |
| Tonix Pharmaceuticals Holding | 179.41M |